FibroBiologics, Inc. amended a previous filing from December 23, 2024, to clarify that it entered into a Standby Equity Purchase Agreement for $15 million, potentially issuing up to 36,945,812 shares upon conversion at $0.406 per share.
AI Assistant
FIBROBIOLOGICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.